Literature DB >> 22048054

Recombinant parathyroid hormone therapy for severe neonatal hypoparathyroidism.

Yoon Hi Cho1, Michel Tchan, Bithi Roy, Robert Halliday, Meredith Wilson, Shoma Dutt, Susan Siew, Craig Munns, Neville Howard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22048054     DOI: 10.1016/j.jpeds.2011.09.022

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  5 in total

1.  Teriparatide (rhPTH 1-34) treatment in the pediatric age: long-term efficacy and safety data in a cohort with genetic hypoparathyroidism.

Authors:  Gerdi Tuli; Raffaele Buganza; Daniele Tessaris; Silvia Einaudi; Patrizia Matarazzo; Luisa de Sanctis
Journal:  Endocrine       Date:  2019-11-08       Impact factor: 3.633

2.  Teriparatide Therapy in a 4-Month-Old With Severe Hypoparathyroidism.

Authors:  Neelam D Bhatt; Julie L Heh; Michelle P Hudspeth; Kelli W Williams; Katherine E Twombley
Journal:  J Pediatr Pharmacol Ther       Date:  2021-12-22

Review 3.  Management of Hypoparathyroidism: Present and Future.

Authors:  John P Bilezikian; Maria Luisa Brandi; Natalie E Cusano; Michael Mannstadt; Lars Rejnmark; René Rizzoli; Mishaela R Rubin; Karen K Winer; Uri A Liberman; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2016-03-03       Impact factor: 5.958

Review 4.  Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus.

Authors:  Aliya A Khan; Christian A Koch; Stan Van Uum; Jean Patrice Baillargeon; Jens Bollerslev; Maria Luisa Brandi; Claudio Marcocci; Lars Rejnmark; Rene Rizzoli; M Zakarea Shrayyef; Rajesh Thakker; Bulent O Yildiz; Bart Clarke
Journal:  Eur J Endocrinol       Date:  2019-03       Impact factor: 6.664

5.  Impact of intercurrent illness on calcium homeostasis in children with hypoparathyroidism: a case series.

Authors:  A Chinoy; M Skae; A Babiker; D Kendall; M Z Mughal; R Padidela
Journal:  Endocr Connect       Date:  2017-11       Impact factor: 3.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.